ECHOGEN is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers, enhance left ventricular border delineation with resulting improvement in wall motion visualisation.
It was originally approved for use in Europe in 1998 but is no longer available on the market.
Contact Dr. Quay
(206) 289-0394
107 Spring Street Seattle, WA 98104
Scam Alert
- Beware of scammers, fraudsters, etc.
- You need to physically see and test items before purchase
- Never advance payment for anything. It is a sign of scam.
Read more